[14C]Artemisinin was taken up by Plasmodiumfalciparum in culture and concentrated in hemozoin. In vitro, hemin and artemisinin were found to undergo a chemical reaction forming two major products which were isolated by highperformance liquid chromatography (HPLC). The m/z values of the two products were 856 and 871. Thin-layer chromatography (TLC) and HPLC of hemozoin isolated from [14C]artemisinin-treated parasites showed that the majority of the hemozoin-associated radioactivity comigrated with the synthetic adducts. When [~4C]artemisinin was incubated with isolated hemozoin, [~4C]artemisinin disappeared from the solution in a time-dependent manner. Some of the radioactivity present in the treated hemozoin also comigrated with the adducts on TLC. Thus, artemisinin appears to react covalently with heme in malaria hemozoin both in vitro and in situ.
have antimalarial activity. One of these synthetic endoperoxides, Ro. 42-1611, is currently undergoing Phase II clinical trials (R. Ridley, Hoffman-LaRoche, personal communication). Thus, the artemisinin derivatives represent a promising new class of antimalarial agents.
Malaria parasites live inside erythrocytes and consume hemoglobin. When heme molecules are released, they polymerize and accumulate in intraparasitic granules known as malaria pigment or hemozoin [4, 5] . We have previously proposed that this accumulation of heme sensitizes malaria parasite to the toxic effects of artemisinin and its derivatives, because it catalyzes the decomposition of the drug into free radicals which act as alkylating agents [6 9] . In this paper we show that artemisinin concentrates in hemozoin where it is cova-lently bound to heine.
Materials and methods
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Chemicals. Artemisinin was purchased from
Aldrich Chemical Company (Milwaukee, WI).
[14C]Artemisinin (45.5 mCi mmol l) was a gift from the Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Washington DC. All other chemicals were purchased from Sigma Chemical Co. (St. Louis, MO).
Isolation ofl malarial hemozoin. P. falciparum
FCR3 strain was cultivated by the method of Traget and Jensen [10] . Hemozoin was isolated from these cultures by a modification of the method of Goldie et al. [11] . Parasite cultures were pooled and the cells were pelleted by centrifugation at 540 x g. The pellet was washed once with RPMI and then lysed by the addition of an equal volume of hypotonic buffer (8 mM potassium phosphate/ 9 mM disodium EDTA, pH 7.2) followed by sonication with a microprobe at maximum intensity for 15 s (Sonifier Cell Disruptor, Heat SystemsUltrasonics, Long island, NY). Crude hemozoin was then pelleted by centrifugation at 35 000 × g at 4°C for 10 rain. The pellet was resuspended in 10 ml hypotonic buffer, sonicated and centrifuged at least thrice, until the supernatant became colorless. The pellet was then resuspended in 1 ml hypotonic buffer and carefully layered on top of 10 ml of 30% sucrose in hypotonic buffer and centrifuged at 35 000 x g for 1 h at 4°C. The hemozoin, at the bottom of the gradient, was removed, washed 3 times with water, resuspended in 1 ml 1% SDS and centrifuged at 13 000 × g. The pellet and pooled supernatants were stored at -80°C.
Synthesis and partial isolation of hemin\artem-isinin adducts.
A 10 mM hemin solution was prepared immediately prior to each experiment by first dissolving hemin in 1 N NaOH, diluting with Tris-HC1 buffer (50 mM pH 8.5) and adjusting the pH to 8.5 with 1 N HCI. Artemisinin was dissolved in methanol as a 10 mM solution and stored at -20°C. Equal volumes of hemin (10 mM) and artemisinin (10 mM) were mixed and incubated in the dark at 37°C for 20 24 h.
The products of the reaction were separated by using high-performance liquid chromatography (HPLC; Rainin Instrument Co. Inc., Woburn, MA) with a 300 x 22.5 mm Bondclone C18 semipreparative column (Phenomenex, Torrance, CA) and a flow rate of 15 ml min 1 by a modification of the methods of Choe and Ortiz de Montellano [12] . The column was eluted with a mixture of methanol/ water/ acetic acid (32:18:5) and monitored at 400 nm. Before each injection, 600 #1 of the reaction mixture was mixed with 400 /~1 of methanol/acetic acid (3:1), clarified by centrifugation and injected. The products collected from the column were concentrated by low pressure distillation using a Buchi Rotary Evaporator (Brinkmann Instruments, Inc., Westbury, NY) until almost dry. The products were redissolved in methanol and rechromatographed by using a mixture of methanol/water/acetic acid (7:3:1) as the elution buffer and concentrated as above. Finally the purified products were dissolved in methanol and stored at -20:C.
Mass spectroscopy. The molecular weights
of the isolated reaction products were determined by two mass spectroscopic methods. Electrospray ionization (ESI) mass spectra were obtained on a model 201 single quadrupole mass spectrometer (Vestec Corp. Houston, TX), with a 2000 m/z range and a Vestec electrospray source. Fast atom bombardment (FAB) ionization mass spectra was obtained on a model 70-250-S mass spectrometer (VG Analytical, Manchester, England), using a fast atom bombardment atom gun with a current of I mA and a voltage of 8 kV. Xenon was the gas ion source.
The reaction of isolated hemozoin and [NC]-artemisinin.
Hemozoin, which was isolated as above from 10 plates of untreated parasites, was incubated with 0.042/tCi [14C]artemisinin in 1 ml of 10% methanol and 90% PBS at 37'~C in the dark. As a control, 0.042 pCi artemisinin was dissolved in the same solution in the absence of hemozoin. 7 #1 of supernatant were removed at 0, 1, 2 and 19 h, respectively.
Fate of radioactivity in drug-treated parasites. Hemozoin, which was isolated from
[xnC]artemisinin-treated parasites or was incubated with []4C]artemisinin as above, was dissolved in 200-300 /d 0.1 N KOH and then precipitated by the addition of one drop of 1 N HC1. After microfuging for 1 rain, the supernatant was discarded and the pellet was redissolved in a mixture of methanol/ water/ acetic acid (32:18:5). 20 ~tl were spotted onto a C18 reversephase fluorescence thin-layer chromatography (TLC) plate (Whatman International Ltd., Maidstone, England) and developed at room temparature with water/acetic acid/methanol (2:1:7). Artemisinin, hemin and the artemisinin-heme adducts isolated from HPLC were used as standards. After each run, the reverse phase plate layer was divided into 0.5-cm fractions and scraped into scintillation vials. 100 /tl of methanol was added to dissolve the drug followed by 10 ml of scintillation fluid. The radioactivity was then counted in a scintillation counter.
Alternatively, hemozoin was dissolved in 0.2 N KOH, mixed with an equal volume of methanol/ acetic acid (9:1) and analyzed by HPLC on a 300 × 3.9 mm /tBondapak C18 analytical column (Waters, Milford MA), eluting at a flow rate of 1 ml min-1 with methanol/water/acetic acid (57:34:9) for 30 min followed by methanol/acetic acid (9:1) for 10 min. [14] . Radioactivity was measured on an LKB 1219 Rackbeta or a Bechman LS 7000 Scintillation counter using Scintivers BD scintillation fluid (Fisher Scientific, Fair Lawn, N J).
Results
When malaria parasites were incubated in the presence of [t4C]artemisinin, more than 40% of the added drug was taken up by the cultures (data not shown). Of the cell-associated radioactivity, only 25% was found in the pooled washes and gradient, which contained more than 99% of the total protein ( Table 1 ). The remainder, 75% of the radioactivity, was associated with the isolated parasite hemozoin. About 1/3 of the hemozoinassociated radioactivity could be extracted with 1% SDS, which solubilized >95% of the pelleted protein ( Table 1 ). The SDS-washed hemozoin pel- let contained the equivalent of 2.3 mmol artemisinin (tool heme) i. In order to understand the interaction of hemin and artemisinin, the two compounds were mixed and allowed to react in solution. Two reaction product peaks were found by HPLC which eluted after the heme peak (Fig. 1) . These peaks were not seen when either reactant was incubated in the same buffer but in the absence of the second reactant (data not shown). The molecular weights of the adducts were then determined by ESI and FAB mass spectroscopy. Both methods gave identical m/z values for heme (616), adduct A (856), and adduct B (871) (Fig. 2) . Hemin, artemisinin and the adducts could also be separated by reverse-phase TLC (Fig. 3) Neither adduct is fluorescent, suggesting that they still contain iron atoms (data not shown). Unfortunately, however, we were unable to successfuly remove the iron from these adducts in order to be able to run NMRs. TLC and HPLC were then used to determine whether these adducts were also formed in vivo. The TLC system used could easily distinguish between artemisinin, heme and the adducts, although not easily between the two adducts ( Fig.  3) When hemozoin was isolated from [14C]artemisinin treated parasites and analyzed by TLC, 77% of the total radioactivity comigrated with the synthetic adducts (Fig. 4) . Similar results were found using HPLC (Fig. 5) Time (mln) Fig. 5 . HPLC profile of purified product A (top) and of radioactivity eluted from an HPLC separation of hemozoin isolated from [~4C]artemisinin treated parasites (bottom). Parasites were exposed to drug as in Table 1 and chromatographed on an analytical column as described in the Materials and Methods. Bottom graph shifted to the left by one minute to compensate for time delay between UV detector and fraction collector. 20% of the hemozoin-associated radioactivity which comigrated with the adducts (not shown). This is the equivalent of incorporating 0.5 mmol of artemisinin per mol of heine.
Discussion
Artemisinin is taken up by malaria parasites and concentrated in hemozoin, possibly by forming adducts. In aqueous solution, artemisinin was found to react with hemin, yielding two major products with molecular weights of 856 and 871. Compounds with identical mobilities on TLC and HPLC were found in hemozoin, when either whole infected red cells of isolated hemozoin was incubated with drug. Thus, artemisinin-heme adducts appear to form in vivo.
The data presented here is consistent with a two-step mode of action of artemisinin, in which the first step consists of the heme-catalyzed cleavage of the endoperoxide bridge to form a free radical and the second step consists of the alkylation of heme and proteins by the drug-derived free radical [15] or other transient drug-derived intermediate [16] . Other evidence consistent with this mechanism includes observations that the endoperoxide bridge is necessary for biological activity [17, 18] and that free radical scavengers and iron chelators antagonize the drug [19 21 ]. The ability of heme and iron to catalyze the decomposition of artemisinin has been demonstrated by cyclic voltametry [7] , by electron paramagnetic resonance spectroscopy [8] and by the isolation and characterization of the decomposition products [16] . Evidence for alkylation of heme [6] and proteins [9] has also been presented previously. This paper is the first time that the heme-artemisinin adducts have been isolated and partially characterized. The synthetic adducts are likely to be identical to the products formed when parasites are treated with 14C-labeled drug because they coelute on both silica TLC and reverse-phase HPLC. The importance of this process is underscored by the observation that about half of the cell-associated radiolabeled drug can be found in SDS-washed, protein-free hemozoin.
In a previous publication, we showed that a crude reaction mixture of heme and artemisinin0 when analyzed by FAB mass spectrometry, gave peaks with rn/z values of 840, 868, 886 and 914 [6] . In contrast, the purified peaks shown here give m/z values of 856 and 871 by both ESI and FAB mass spectrometry. The differences between the two observations may be due to differences in the reaction conditions, as well as to the possibility that the impure reaction mixture contained components which were not observed by HPLC since the eluate was monitored at 400 nm, a wavelength which is characteristic of compounds containing porphyrin rings [14] . Interestingly the MW of adduct B, 871, is 18 less than that of the sum of artemisinin (282.4) and heme (616.5) suggesting a dehydration.
More artemisinin concentrates in hemozoin obtained from [14C]artemisinin-treated infected red cells (2.3 mmol mol i heme) than by exposing isolated hemozoin to the labeled drug (0.5 mmol tool i heme). There are two possible reasons for this. First, the heine-catalyzed decomposition of artemisinin is reductive [16] , suggesting that ferrous heme (Fe +2) is more reactive than ferric heme (Fe+3). Heme is more likely to be in the reduced state in vivo than in solution because of the presence of intracellular reducing agents such as glutathione. Second, in vivo, heme may react with artemisinin in the brief time period between when it is liberated from hemoglobin and poly-merized to hemozoin [4] . Once incorporated into hemozoin, only the heme molecules on the surface of the granules are likely to be reactive with artemisinin, since the iron atoms of the interior molecules may be sequestered by iron-carboxylate bonds [5] .
What role does the formation heme-artemisinin adducts play in the drug-mediated killing of malaria parasites? The heme-artemisinin adduct is not toxic to in vitro cultures of P. falciparum when added to the media [6] . When parasites are grown in resealed red cells containing an excess of heme, they appear to be protected from artemisinin, presumably because the adducts form in the red cell cytoplasm (unpublished results). However, the CR strain of P. berghei, which lacks hemozoin, is resistant to artemisinin [22] . Furthermore, threequarters of the cell-associated drug winds up in hemozoin, of which two-thirds (half of the total) remains even after SDS extraction of protein.
Thus, the formation of artemisinin-heme adducts play important but as yet undefined roles in the mode of action of this drug. "
